Rmb Capital Management, LLC Grifols Sa Transaction History

Rmb Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 10, 2020	SELL	$15.4 - $20.16 $4.3 Million - $5.63 Million	-279,186 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$18.24 - $21.45 $281,279 - $330,780	-15,421 Reduced 5.23%	279,186 $5.09 Million
Q1 2020 May 11, 2020	BUY	$16.28 - $25.63 $2.64 Million - $4.15 Million	161,867 Added 121.94%	294,607 $5.93 Million
Q4 2019 Feb 13, 2020	SELL	$19.57 - $23.52 $1.67 Million - $2 Million	-85,203 Reduced 39.09%	132,740 $3.09 Million
Q3 2019 Nov 12, 2019	BUY	$19.85 - $22.76 $4.33 Million - $4.96 Million	217,943 New	217,943 $4.37 Million

162

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $6.43B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rmb Capital Management, LLC with notifications on news.